NCT07687576

Brief Summary

The CAPTURE AMI trial is an investigator-initiated, single-centre, two-arm, randomised controlled trial. Patients aged ≥ 18 years who present with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) will be enrolled after angiographic evidence of a high thrombus burden (TIMI thrombus grade ≥ 4) and meeting the inclusion criteria laid out in section 9.2 will be 1:1 randomised to receive either standalone PCI (Arm 1) or adjunct sustained mechanical thrombectomy + PCI (Arm 2). The CAPTURE AMI study will enrol specifically patients with: A. Evidence of high thrombus burden on coronary angiography (TIMI thrombus grade ≥ 4) B. Culprit in an artery with a diameter of 3.0 mm or more. The trial is designed to evaluate the efficacy of sustained mechanical thrombectomy versus standalone PCI in patients with a large thrombus burden assessed angiographically, with a pre-stent thrombus burden (%) as the primary imaging endpoint.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for phase_2

Timeline
17mo left

Started Jul 2026

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Jul 2026Jan 2028

First Submitted

Initial submission to the registry

June 25, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 7, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

July 8, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 8, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2028

Last Updated

July 10, 2026

Status Verified

June 1, 2026

Enrollment Period

1 year

First QC Date

June 25, 2026

Last Update Submit

July 8, 2026

Conditions

Keywords

ThrombusThrombectomyOptical Coherence TomographyMicrovascular Injury

Outcome Measures

Primary Outcomes (1)

  • Pre stent Thrombus Burden

    Pre stent Thrombus Burden (thrombus volume/lumen volume) evaluated by Optical Coherence Tomography

    Pre stent implantation (Periprocedural)

Other Outcomes (6)

  • Clinical Outcomes

    In hospital (Pre-discharge), 30 days & 6 months

  • Efficacy of thrombus burden reduction

    Pre stent implantation (Periprocedural)

  • Efficacy of thrombus burden reduction

    Pre stent Implantation (Periprocedural)

  • +3 more other outcomes

Study Arms (2)

Standalone PCI

ACTIVE COMPARATOR

Standalone OCT guided PCI

Procedure: Percutaneous Coronary Intervention

PCI & Sustained thrombectomy

EXPERIMENTAL

OCT guided PCI \& Sustained Thrombectomy

Device: Sustained thrombectomyProcedure: Percutaneous Coronary Intervention

Interventions

Sustained thrombectomy with the Indigo® System CAT™ RX aspiration catheter

PCI & Sustained thrombectomy

Optical Coherence Tomography guided Percutaneous Coronary Intervention

PCI & Sustained thrombectomyStandalone PCI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary PCI patient with ST elevation myocardial infarction
  • Angiographic criteria:
  • TIMI 0/1 flow at presentation
  • Angiographic thrombus score ≥ 4
  • Vessel diameter at site of occlusion ≥ 3.0mm (determined by coronary angiography)

You may not qualify if:

  • Female participant who is pregnant or lactating
  • Unconscious at presentation
  • Late STEMI presentation (symptoms onset to wire time \> 12 h)
  • Clinically/haemodynamically unstable patients
  • Known diagnosis of severe renal disease (CKD stage 4-5)
  • Suspected spontaneous coronary artery dissection
  • Previous CABG
  • Previous history on STEMI in the same culprit territory
  • Known moderate-severe anaemia (Hb \< 9)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oxford Heart Centre - John Radcliffe Hospital

Oxford, Oxfordshire, OX3 9DU, United Kingdom

RECRUITING

Related Publications (3)

  • Kotronias RA, Walsh JL, Andreaggi S, Portolan L, Maino A, Marin F, Chai J, Sobirov I, Sheikh M, Cahill TJ, Lucking AJ, Costello M, Fraile Moreno E, Haridas V, Shaji A, Garcia-Garcia HM, Channon KM, Banning AP, Langrish JP, De Maria GL; OxAMI and RETRIEVE AMI Investigators. Stent-Retriever Thrombectomy in STEMI With Large Thrombus Burden: The RETRIEVE AMI Randomized Trial. JACC Adv. 2025 Jul;4(7):101893. doi: 10.1016/j.jacadv.2025.101893. Epub 2025 Jun 23.

    PMID: 40555011BACKGROUND
  • Walsh JL, Kotronias RA, Banning AP, De Maria GL. Interventional thrombus modification in STEMI. Nat Rev Cardiol. 2024 Jul;21(7):435-436. doi: 10.1038/s41569-024-01020-2. No abstract available.

    PMID: 38565957BACKGROUND
  • Kotronias RA, Marin F, Emfietzoglou M, Langrish JP, Lucking AJ, Channon KM, Banning AP, De Maria GL. Rationale and Design of a Randomized Controlled Pilot Trial to Assess Stent Retriever Thrombectomy for Thrombus Burden Reduction in Patients with Acute Myocardial Infarction: The RETRIEVE-AMI Study. Cardiovasc Revasc Med. 2023 Jul;52:75-85. doi: 10.1016/j.carrev.2023.02.012. Epub 2023 Mar 6.

    PMID: 36894360BACKGROUND

MeSH Terms

Conditions

ST Elevation Myocardial InfarctionThrombosis

Interventions

Percutaneous Coronary Intervention

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisEmbolism and Thrombosis

Intervention Hierarchy (Ancestors)

Endovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Central Study Contacts

Giovanni Luigi De Maria, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Primary Investigator

Study Record Dates

First Submitted

June 25, 2026

First Posted

July 7, 2026

Study Start

July 8, 2026

Primary Completion (Estimated)

July 8, 2027

Study Completion (Estimated)

January 8, 2028

Last Updated

July 10, 2026

Record last verified: 2026-06

Locations